Laurence Wright

Comparison of dalbavancin to standard-of-care for outpatient treatment of invasive Gram-positive infections

Michael P. Veve, Nimish Patel, Zachary A. Smith et al. · International Journal of Antimicrobial Agents · 2020 · 47 citations

Pharmacy, Infectious Diseases, Pharmacology +11

Scaffold Hopping with Molecular Field Points:  Identification of a Cholecystokinin-2 (CCK₂) Receptor Pharmacophore and Its Use in the Design of a Prototypical Series of Pyrrole- and Imidazole-Based CCK₂ Antagonists

Caroline M. R. Low, Ildiko M. Buck, Tracey Cooke et al. · Journal of Medicinal Chemistry · 2005 · 42 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Optimization of 1,3,4-Benzotriazepine-Based CCK₂ Antagonists to Obtain Potent, Orally Active Inhibitors of Gastrin-Mediated Gastric Acid Secretion

Iain M. McDonald, J.W. Black, Ildiko M. Buck et al. · Journal of Medicinal Chemistry · 2007 · 36 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Comparison of linezolid step-down therapy to standard parenteral therapy in methicillin-resistant Staphylococcus aureus bloodstream infections

Samantha D. Yeager, Justin E. Oliver, Mahmoud Shorman et al. · International Journal of Antimicrobial Agents · 2021 · 35 citations

Life Sciences, Infectious Diseases, Microbiology +11

Optimization of the in Vitro and in Vivo Properties of a Novel Series of 2,4,5-Trisubstituted Imidazoles as Potent Cholecystokinin-2 (CCK₂) Antagonists

Ildiko M. Buck, J.W. Black, Tracey Cooke et al. · Journal of Medicinal Chemistry · 2005 · 19 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17